Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:54 AM
Ignite Modification Date:
2025-12-25 @ 3:54 AM
NCT ID:
NCT04058002
Eligibility Criteria:
Inclusion Criteria:
* Men and women diagnosed with OAJ with or without metabolic syndrome (ie at least two of: overweight / obese, hyperglycemia, dyslipidemia, hypertension)
* Age greater than or equal to 70 years.
* Classified as degrees I to III of Kelgreen and Lawrence (K-L), that is, any degree of gonarthritis without obliteration of joint space.
* Indication of clinical treatment of OA
* Patients without disabsorbing syndrome or inflammatory diseases of the gastrointestinal tract (GIT).
* Patients not undergoing gastroplasty or surgery that altered the transit of food in the TGI (Roux "Y", for example).
* Patients with creatinine clearance greater than 60 ml / min / 1.73m2
* Patients not submitted to previous arthroplasty in the lower limbs.
* Patients not submitted to infiltration in the knees up to 6 months before the study.
* Patients with no personal history of cognitive, psychiatric and / or neurological disorders, whose symptoms presented at the time of evaluation are related or significantly interfere with the functions of attention, memory, logical reasoning, comprehension, in order to impair the assimilation of the given guidelines.
* Ability to read, understand and respond to the questionnaires
Exclusion Criteria:
* Missing the schedules and not performing the tasks as performed by the professionals.
* Patients who develop allergy or intolerance to creatine, dextrose or BCAA during the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
70 Years
Study:
NCT04058002
Study Brief:
Protocol Section:
NCT04058002